![]() |
|
|
1st Department of Medicine, 2AFES, J. W. Goethe University, 60590 Frankfurt/Main, Germany
3To whom correspondence should be addressed. E-mail: j.stein{at}em.uni-frankfurt.de.
Resveratrol (3,4',5-trihydroxy-trans-stilbene), a phytoalexin found in grape skins, peanuts, and red wine, has been reported to exhibit a wide range of biological and pharmacological properties. It has been speculated that dietary resveratrol may act as an antioxidant, promote nitric oxide production, inhibit platelet aggregation, and increase high-density lipoprotein cholesterol and thereby serve as a cardioprotective agent (the so-called "French paradox"). Recently, it was demonstrated that resveratrol can function as a cancer chemopreventive agent, and there has been a great deal of experimental effort directed toward defining this effect. It has been shown that resveratrol and some of its analogues interfere with signal transduction pathways. Thus the activities of various protein kinases are inhibited, the expression of nuclear proto-oncogenes declines, and the activity of ornithine decarboxylase (ODC) is reduced. ODC, which catalyzes the rate-limiting step in the biosynthesis of polyamines, is closely linked with cellular proliferation and carcinogenesis. This review summarizes the recent advances that have provided new insights into the molecular mechanisms underlying the promising properties of resveratrol focusing on the key role of the polyamine metabolism in colorectal cancer cells.
KEY WORDS: resveratrol piceatannol human cancer cells polyamines
This article has been cited by other articles:
![]() |
F. Kolahdooz, T. I Ibiebele, J. C van der Pols, and P. M Webb Dietary patterns and ovarian cancer risk Am. J. Clinical Nutrition, January 1, 2009; 89(1): 297 - 304. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ulrich, S. M. Loitsch, O. Rau, A. von Knethen, B. Brune, M. Schubert-Zsilavecz, and J. M. Stein Peroxisome Proliferator-Activated Receptor {gamma} as a Molecular Target of Resveratrol-Induced Modulation of Polyamine Metabolism. Cancer Res., July 15, 2006; 66(14): 7348 - 7354. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Grosch, T. J. Maier, S. Schiffmann, and G. Geisslinger Cyclooxygenase-2 (COX-2)-independent anticarcinogenic effects of selective COX-2 inhibitors. J Natl Cancer Inst, June 7, 2006; 98(11): 736 - 747. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Blumenstein, B. Keseru, F. Wolter, and J. Stein The Chemopreventive Agent Resveratrol Stimulates Cyclic AMP-Dependent Chloride Secretion In vitro Clin. Cancer Res., August 1, 2005; 11(15): 5651 - 5656. [Abstract] [Full Text] [PDF] |
||||